Literature DB >> 31768917

Synthesizing Markers of Kidney Injury in Acute Decompensated Heart Failure: Should We Even Keep Looking?

Alexander S Manguba1, Xavier Vela Parada1, Steven G Coca2, Anuradha Lala3.   

Abstract

PURPOSE OF REVIEW: This review discusses evidence that has accumulated over the years on the diagnostic and prognostic utility of biomarkers of kidney injury in the setting of acute decompensated heart failure. RECENT
FINDINGS: Despite numerous studies evaluating several different biomarkers both in the serum and urine, the current body of evidence does not support routine use of any of these biomarkers for the purposes of diagnosis of acute kidney injury or for prognosis after hospitalization for acute decompensated heart failure. All studies are observational in nature and, as such, are likely limited by numerous confounders, the most important of which is modification of decongestive therapy in response to worsening renal function. More recent evidence suggests that worsening renal function or kidney injury does not always portend poor outcomes after hospitalization for heart failure. There is currently no conclusive evidence to recommend the routine use of biomarkers of kidney injury in acute decompensated heart failure.

Entities:  

Keywords:  Acute decompensated heart failure; Acute kidney injury; Biomarkers; Cardiorenal syndrome; Worsening renal function

Mesh:

Substances:

Year:  2019        PMID: 31768917     DOI: 10.1007/s11897-019-00448-9

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  89 in total

1.  Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues.

Authors:  Andrea Mortara; Marika Bonadies; Simone Mazzetti; Ilenia Fracchioni; Pietro Delfino; Margherita Chioffi; Chiara Bersano; Giuseppe Specchia
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2013-09       Impact factor: 2.160

2.  Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.

Authors:  Johanna E Emmens; Jozine M Ter Maaten; Yuya Matsue; Marco Metra; Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Gad Cotter; Beth Davison; John G Cleland; Michael M Givertz; Daniel M Bloomfield; Howard C Dittrich; John Todd; Dirk J van Veldhuisen; Hans L Hillege; Kevin Damman; Peter van der Meer; Adriaan A Voors
Journal:  Eur J Heart Fail       Date:  2015-10-28       Impact factor: 15.534

3.  Diagnostic and prognostic value of cystatin C in acute heart failure.

Authors:  Tobias Breidthardt; Zaid Sabti; Ronny Ziller; Frank Rassouli; Raphael Twerenbold; Nikola Kozhuharov; Etienne Gayat; Samyut Shrestha; Sara Barata; Patrick Badertscher; Jasper Boeddinghaus; Thomas Nestelberger; Christian Mueller
Journal:  Clin Biochem       Date:  2017-07-26       Impact factor: 3.281

4.  The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.

Authors:  Colette E Jackson; Caroline Haig; Paul Welsh; Jonathan R Dalzell; Ioannis K Tsorlalis; Alex McConnachie; David Preiss; Stefan D Anker; Naveed Sattar; Mark C Petrie; Roy S Gardner; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2016-04-25       Impact factor: 15.534

5.  Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation.

Authors:  Hideaki Inazumi; Satoshi Koyama; Yohei Tanada; Hisayoshi Fujiwara; Yoshiki Takatsu; Yukihito Sato
Journal:  J Cardiol       Date:  2015-06-15       Impact factor: 3.159

6.  The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.

Authors:  Peter van der Meer; Douwe Postmus; Piotr Ponikowski; John G Cleland; Christopher M O'Connor; Gad Cotter; Marco Metra; Beth A Davison; Michael M Givertz; George A Mansoor; John R Teerlink; Barry M Massie; Hans L Hillege; Adriaan A Voors
Journal:  J Am Coll Cardiol       Date:  2013-03-14       Impact factor: 24.094

Review 7.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Authors:  Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

Review 8.  Beta-trace protein as a marker of GFR--history, indications, and future research.

Authors:  Guido Filler; Carola Kusserow; Laudelino Lopes; Marta Kobrzyński
Journal:  Clin Biochem       Date:  2014-05-12       Impact factor: 3.281

9.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

10.  Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome.

Authors:  Zhong-Bao Ruan; Li Zhu; Yi-Gang Yin; Ge-Cai Chen
Journal:  J Res Med Sci       Date:  2014-05       Impact factor: 1.852

View more
  4 in total

1.  Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure.

Authors:  Elisa Diaz-Riera; Maisa García-Arguinzonis; Laura López; Xavier Garcia-Moll; Lina Badimon; Teresa Padró
Journal:  Front Cardiovasc Med       Date:  2022-06-09

2.  Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury.

Authors:  Ryo Kawakami; Miki Matsui; Ayumu Konno; Ryosuke Kaneko; Shreya Shrestha; Suman Shrestha; Hiroaki Sunaga; Hirofumi Hanaoka; Sawako Goto; Michihiro Hosojima; Hideyuki Kabasawa; Masaru Obokata; Norimichi Koitabashi; Hiroki Matsui; Tsutomu Sasaki; Akihiko Saito; Motoko Yanagita; Hirokazu Hirai; Masahiko Kurabayashi; Tatsuya Iso
Journal:  J Pathol       Date:  2021-09-01       Impact factor: 9.883

3.  Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure.

Authors:  Evelyn M Templeton; Moritz Lassé; Torsten Kleffmann; Leigh J Ellmers; Suetonia C Palmer; Trent Davidson; Nicola J A Scott; John W Pickering; Christopher J Charles; Zoltan H Endre; Vicky A Cameron; A Mark Richards; Miriam T Rademaker; Anna P Pilbrow
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

4.  Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.

Authors:  Ming-Jen Chan; Yung-Chang Chen; Pei-Chun Fan; Cheng-Chia Lee; George Kou; Chih-Hsiang Chang
Journal:  Biomedicines       Date:  2022-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.